Ng WH, Yeo YH, Kim H, Seki E, et al. Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction-associated steatotic liver diseases: Target trial emulation using real-world data. Hepatology 2026;83:333-343.
PMID: 40178454